Showing results (2121-2130 of 2,605) with videos related to

Sort By:
Pageof 261
Aging Cell|October 17, 2015
Reduced naïve CD8(+) T-cell priming efficacy in elderly adultsOlivia Briceño, Anna Lissina, Kerstin Wanke, et al.
Med (New York, N.Y.)|February 15, 2024
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVIDKirsten Baillie, Helen E Davies, Samuel B K Keat, et al.
Blood|March 15, 2011
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infectionTakuya Yamamoto, David A Price, Joseph P Casazza, et al.
Oral Oncology|June 19, 2018
Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinomaDario Pasalic, Ryan K Funk, Joaquín J García, et al.
Pharmacogenetics|May 8, 2001
MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicityM M Ameyaw, F Regateiro, T Li, et al.
Radiation Protection Dosimetry|December 31, 2005
QUADOS intercomparison: a summary of photon and charged particle problemsG Gualdrini, S Agosteo, S Ménard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
Inorganic Chemistry|September 24, 2015
Intracellular distribution of fluorescent copper and zinc bis(thiosemicarbazonato) complexes measured with fluorescence lifetime spectroscopyJames L Hickey, Janine L James, Clare A Henderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2014
Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficientsConan K Wang, Susan E Northfield, Barbara Colless, et al.
Frontiers in Oncology|March 14, 2022
Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast CancerZhe-Yu Hu, Chanjuan Zheng, Jianbo Yang, et al.
Pageof 261